Nature Reviews Drug Discovery
 | |
| Discipline | Pharmacology, biotechnology |
|---|---|
| Language | English |
| Edited by | Peter Kirkpatrick |
| Publication details | |
| History | 2002-present |
| Publisher | Nature Publishing Group |
| Frequency | Monthly |
| 84.694 (2020) | |
| Standard abbreviations | |
| ISO 4 | Nat. Rev. Drug Discov. |
| Indexing | |
| CODEN | NRDDAG |
| ISSN | 1474-1776 (print) 1474-1784 (web) |
| LCCN | 2002243044 |
| OCLC no. | 427380493 |
| Links | |
)Nature Reviews Drug Discovery is a peer-reviewed review journal covering drug discovery and development. According to the Journal Citation Reports, the journal has a 2020 impact factor of 84.694.[1]
Reviews are commissioned to specialists and supplemented with glossary explanations for non-specialist readers and illustrated with figures drawn by Nature's in-house art editors. Besides reviews, the journal publishes analysis articles based on existing datasets (e.g. metaanalysis), progress articles that focus on outstanding issues, and perspective articles—typically opinions or historical pieces.[2]
See also[]
References[]
- ^ "Nature Reviews Drug Discovery". 2020 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2021.
- ^ Guide : Information : Nature Reviews Drug Discovery. Nature.com. Retrieved on 2011-06-29.
External links[]
| Holtzbrinck |
|  | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Macmillan |
| ||||||||||||
| Springer Nature (53%) |
| ||||||||||||
  | This article about a medical journal is a stub. You can help Wikipedia by . See tips for writing articles about academic journals. Further suggestions might be found on the article's talk page. |
- Pharmacology journals
- Nature Research academic journals
- English-language journals
- Monthly journals
- Publications established in 2002
- Medical journal stubs